AmSurg (AMSG) Tops Q2 EPS by 2c

AmSurg (NASDAQ: AMSG) reported Q2 EPS of $1.10, $0.02 better than the analyst estimate of $1.08. Revenue for the quarter came in at $758.5 million versus the consensus estimate of $769.88 million.

GUIDANCE:

AmSurg sees FY2016 EPS of $4.28-$4.35. AmSurg sees FY2016 revenue of $3.05-3.09 million.

For earnings history and earnings-related data on AmSurg (AMSG) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance